Legacy Wealth Management, LLC / Ms Vertex Pharmaceuticals Inc Transaction History

Legacy Wealth Management, LLC / Ms

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Dec 12, 2024	SELL	$181.39 - $202.99 $216,942 - $242,776	-1,196 Closed	0 $0
Q2 2021 Dec 12, 2024	SELL	$187.49 - $221.1 $196,864 - $232,155	-1,050 Reduced 46.75%	1,196 $241 Million
Q1 2021 Dec 12, 2024	SELL	$207.02 - $241.31 $3,726 - $4,343	-18 Reduced 0.8%	2,246 $483 Million
Q2 2020 Dec 12, 2024	BUY	$225.48 - $295.8 $24,126 - $31,650	107 Added 4.96%	2,264 $657 Million
Q1 2020 Dec 12, 2024	BUY	$199.77 - $247.81 $430,903 - $534,526	2,157 New	2,157 $513 Million

1,726

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Legacy Wealth Management, LLC / Ms, based on Form 13F filings with the SEC.

Stay updated on Legacy Wealth Management, LLC / Ms with notifications on news.